Celldex Therapeutics Cash Conversion Cycle 2011-2026 | CLDX

Annual Cash Conversion Cycle Celldex Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
-3.74 K	-6.08 K	-4.08 K	-8.3 K	-4.08 K	-1.96 K	-	-	-	-	-	-	-307	-23.8	-30.7	1.26	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.26	-8.3 K	-2.86 K

Quarterly Cash Conversion Cycle Celldex Therapeutics

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	72.1	116	-	34.1	76.8	1.55 K	-	11.1	244	78.4	-	32.1	95.2	109	-	207	30.5	242	43.4	246	697	47.1	104	170	130	134	164	307	104	56.5	49.6	43.7	44.8	109	86.9	73.3	117	96.4	49.5	86.3	40.6	131	26.4	35.4	65.8	100	72	45.5	460	10.1	1.1	1.29	2	4.01	6.38	6.56	7.95	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.55 K	1.1	130

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	3.11 K	-	5743.5 %	$ 69.7 M	Canada
Happiness Biotech Group Limited HAPP	-3.12 K	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	-1.97 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
AstraZeneca PLC AZN	-58	-	-	$ 96.9 B	Britain
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Esperion Therapeutics ESPR	99.7	$ 3.13	-	$ 651 M	USA
Eton Pharmaceuticals ETON	115	$ 34.45	4.74 %	$ 927 M	USA
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Grifols, S.A. GRFS	0.000171	$ 8.19	4.46 %	$ 5.57 B	Spain
Celyad Oncology SA CYAD	-55.7 K	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	214	-	-7.31 %	$ 87 M	USA
Arcturus Therapeutics Holdings ARCT	21.2	$ 6.82	1.94 %	$ 187 M	Israel
Generation Bio Co. GBIO	47.6	-	-	$ 344 M	USA
Autolus Therapeutics plc AUTL	119	$ 1.62	-0.61 %	$ 431 M	Britain
Ayala Pharmaceuticals AYLA	-2.15 K	-	-	$ 7.46 M	Israel
Cyclacel Pharmaceuticals CYCCP	-1.6 K	-	-4.36 %	$ 27 M	USA
Compugen Ltd. CGEN	-82.7	$ 2.71	-0.92 %	$ 253 M	Israel
Anika Therapeutics ANIK	192	$ 15.14	2.16 %	$ 217 M	USA
Advaxis ADXS	-82.3 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	-34.3 K	-	5.93 %	$ 314 M	Canada
Incyte Corporation INCY	-54.7	$ 97.08	1.55 %	$ 19 B	USA
Applied Genetic Technologies Corporation AGTC	126	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	-1.92	-	1.93 %	$ 17.4 M	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Coherus BioSciences CHRS	149	$ 1.51	2.03 %	$ 177 M	USA
Albireo Pharma ALBO	-1.55 K	-	-0.23 %	$ 916 M	USA
Arcutis Biotherapeutics ARQT	158	$ 20.47	4.97 %	$ 2.6 B	USA
Ampio Pharmaceuticals AMPE	-4.62 K	-	-11.43 %	$ 502 K	USA